Bicycle Therapeutics names business chief
This article was originally published in Scrip
Executive Summary
Cambridge, UK-based Bicycle Therapeutics, an emerging biotech company developing first-in-class bicyclic peptide targeted drugs, has named Arvind Hundal president and chief business officer. Dr Hundal has more than 20 years' experience in the life sciences sector, the majority of which have been in business development and strategy roles. She was most recently chief business officer and senior management team member at Zealand Pharma and was a part of the team that lead the successful initial public offering in 2010.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.